10x Genomicsの内部者の所有権
10x Genomicsの内部者の所有権は何ですか。
10x Genomics, Inc.の内部者の所有権は2.46%です。
内部者の所有権の定義は何ですか。
管理の所有権(Insider Ownership)は、発行済株式総数で除したインサイダー（5％超を所有する株主または取締役または役員) が所有する株式総数によって計算されます。
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
NASDAQのセクタHealth Careにおける内部者の所有権の企業と比べる10x Genomics
10x Genomicsは何をしますか。
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
10x Genomicsと類似の内部者の所有権
- Lantheus Incの内部者の所有権は2.45%です。
- Verimatrix Societe anonymeの内部者の所有権は2.45%です。
- Intra-Cellular Therapies Incの内部者の所有権は2.45%です。
- NewAge Incの内部者の所有権は2.45%です。
- Pucara Goldの内部者の所有権は2.45%です。
- Insmed Incの内部者の所有権は2.46%です。
- 10x Genomicsの内部者の所有権は2.46%です。
- Federal Signalの内部者の所有権は2.47%です。
- Beazley Plcの内部者の所有権は2.47%です。
- NeoPhotonicsの内部者の所有権は2.47%です。
- ChannelAdvisor Corpの内部者の所有権は2.47%です。
- Pacton Goldの内部者の所有権は2.47%です。
- Abercrombie & Fitch Coの内部者の所有権は2.47%です。